• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前骨骼肌指数低会增加可切除胰腺癌患者的死亡风险:一项回顾性研究。

Low preoperative skeletal muscle index increases the risk of mortality among resectable pancreatic cancer patients: A retrospective study.

作者信息

Cai Zhi-Wei, Li Jia-Lin, Liu Meng, Wang Hong-Wei, Jiang Chong-Yi

机构信息

Department of General Surgery, Hepato-Biliary-Pancreatic Center, Huadong Hospital, Shanghai 200040, China.

Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.

出版信息

World J Gastrointest Surg. 2022 Dec 27;14(12):1350-1362. doi: 10.4240/wjgs.v14.i12.1350.

DOI:10.4240/wjgs.v14.i12.1350
PMID:36632124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9827571/
Abstract

BACKGROUND

The only potential curative treatment for patients with pancreatic cancer is surgery; however, the prognosis remains poor. Measures of body composition based on computed tomography (CT) have been established as a reliable predictor of the prognosis of cancer patients after surgery.

AIM

To elucidate the associations of body composition measures derived from preoperative CT scans with the prognosis of patients with pancreatic cancer.

METHODS

One hundred fifteen patients undergoing pancreatic resection with curative intent for pancreatic cancer were retrospectively enrolled. A preoperative CT scan at the third lumbar vertebral level was performed to measure the skeletal muscle index (SMI), mean skeletal muscle radiodensity, subcutaneous adipose tissue index, and visceral to subcutaneous adipose tissue area ratio. The clinical and pathological data were collected. The effects of these factors on long-term survival were evaluated.

RESULTS

Among the five body composition measures, only low SMI independently predicted overall survival (OS) [hazard ratio (HR): 2.307; 95% confidence interval (CI): 1.210-4.402] and recurrence-free survival (HR: 1.907; 95%CI: 1.147-3.171). Furthermore, patients with low SMI ( high SMI) were older (68.8 ± 9.3 years 63.3 ± 8.4 years); low SMI was present in 27 of 56 patients (48.2%) aged 65 years and older and in 11 of 59 younger patients (18.6%). In addition, subgroup analyses revealed that the correlation between low SMI and OS was observed only in patients aged 65 years and older.

CONCLUSION

Low preoperative SMI was more prevalent in elderly patients and was associated with a poor prognosis among pancreatic cancer patients, especially elderly patients.

摘要

背景

胰腺癌患者唯一可能的治愈性治疗方法是手术;然而,其预后仍然很差。基于计算机断层扫描(CT)的身体成分测量已被确立为癌症患者术后预后的可靠预测指标。

目的

阐明术前CT扫描得出的身体成分测量指标与胰腺癌患者预后之间的关联。

方法

回顾性纳入115例接受胰腺癌根治性切除的患者。在第三腰椎水平进行术前CT扫描,以测量骨骼肌指数(SMI)、平均骨骼肌放射密度、皮下脂肪组织指数以及内脏与皮下脂肪组织面积比。收集临床和病理数据。评估这些因素对长期生存的影响。

结果

在五项身体成分测量指标中,只有低SMI独立预测总生存期(OS)[风险比(HR):2.307;95%置信区间(CI):1.210 - 4.402]和无复发生存期(HR:1.907;95%CI:1.147 - 3.171)。此外,低SMI(高SMI)患者年龄更大(68.8±9.3岁 63.3±8.4岁);56例65岁及以上患者中有27例(48.2%)存在低SMI,59例年轻患者中有11例(18.6%)存在低SMI。此外,亚组分析显示,仅在65岁及以上患者中观察到低SMI与OS之间的相关性。

结论

术前低SMI在老年患者中更为普遍,并且与胰腺癌患者,尤其是老年患者的不良预后相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900a/9827571/880b775f76ee/WJGS-14-1350-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900a/9827571/75ff7ad027a2/WJGS-14-1350-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900a/9827571/08d7a05a46cc/WJGS-14-1350-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900a/9827571/880b775f76ee/WJGS-14-1350-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900a/9827571/75ff7ad027a2/WJGS-14-1350-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900a/9827571/08d7a05a46cc/WJGS-14-1350-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900a/9827571/880b775f76ee/WJGS-14-1350-g003.jpg

相似文献

1
Low preoperative skeletal muscle index increases the risk of mortality among resectable pancreatic cancer patients: A retrospective study.术前骨骼肌指数低会增加可切除胰腺癌患者的死亡风险:一项回顾性研究。
World J Gastrointest Surg. 2022 Dec 27;14(12):1350-1362. doi: 10.4240/wjgs.v14.i12.1350.
2
Bidirectional association between perioperative skeletal muscle and subcutaneous fat in colorectal cancer patients and their prognostic significance.结直肠癌患者围手术期骨骼肌与皮下脂肪的双向关联及其预后意义。
Front Nutr. 2024 Sep 18;11:1381995. doi: 10.3389/fnut.2024.1381995. eCollection 2024.
3
Prognostic value of initial and longitudinal changes in body composition in metastatic pancreatic cancer.转移性胰腺癌中体成分的初始和纵向变化的预后价值。
J Cachexia Sarcopenia Muscle. 2024 Apr;15(2):735-745. doi: 10.1002/jcsm.13437. Epub 2024 Feb 8.
4
Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.胰腺癌一线化疗患者骨骼肌密度和肌肉减少症的临床意义:一项回顾性观察研究。
BMC Cancer. 2021 Jan 18;21(1):77. doi: 10.1186/s12885-020-07753-w.
5
Impact of preoperative body compositions on survival following resection of biliary tract cancer.术前体成分对胆道癌切除术后生存的影响。
J Cachexia Sarcopenia Muscle. 2019 Aug;10(4):794-802. doi: 10.1002/jcsm.12431. Epub 2019 Apr 29.
6
Sarcopenia as a Predictor of Survival in Patients with Pancreatic Adenocarcinoma After Pancreatectomy.肌肉减少症作为胰腺导管腺癌患者胰十二指肠切除术后生存的预测指标
Ann Surg Oncol. 2022 Mar;29(3):1553-1563. doi: 10.1245/s10434-021-10995-y. Epub 2021 Oct 30.
7
Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer.原发性减瘤手术和化疗过程中的肌肉丢失可预测晚期卵巢癌的不良预后。
J Cachexia Sarcopenia Muscle. 2020 Apr;11(2):534-546. doi: 10.1002/jcsm.12524. Epub 2020 Jan 30.
8
Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer.内脏脂肪堆积和肌少型内脏肥胖与胰腺癌切除术后预后不良相关。
Ann Surg Oncol. 2017 Nov;24(12):3732-3740. doi: 10.1245/s10434-017-6077-y. Epub 2017 Sep 5.
9
Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.术前肌少症与胰十二指肠切除术后胰腺癌患者的总体生存不良相关。
Eur Radiol. 2021 Apr;31(4):2472-2481. doi: 10.1007/s00330-020-07294-7. Epub 2020 Sep 24.
10
Prognostic values of abdominal body compositions on survival in advanced pancreatic cancer.晚期胰腺癌腹部身体成分对生存的预后价值
Medicine (Baltimore). 2018 Jun;97(22):e10988. doi: 10.1097/MD.0000000000010988.

引用本文的文献

1
Looking at or beyond the tumor - a systematic review and meta-analysis of quantitative imaging biomarkers predicting pancreatic cancer prognosis.观察肿瘤内部或外部——对预测胰腺癌预后的定量成像生物标志物的系统评价和荟萃分析
Abdom Radiol (NY). 2025 Apr 8. doi: 10.1007/s00261-025-04919-7.
2
Computed Tomography-Based Sarcopenia and Pancreatic Cancer Survival-A Comprehensive Meta-Analysis Exploring the Influence of Definition Criteria, Prevalence, and Treatment Intention.基于计算机断层扫描的肌肉减少症与胰腺癌生存率——一项探索定义标准、患病率及治疗意向影响的综合荟萃分析
Cancers (Basel). 2025 Feb 11;17(4):607. doi: 10.3390/cancers17040607.
3

本文引用的文献

1
Sarcopenia: Prognostic Value for Unresectable Pancreatic Ductal Adenocarcinoma Patients Treated With Gemcitabine Plus Nab-Paclitaxel.肌肉减少症:吉西他滨联合 Nab-紫杉醇治疗不可切除胰腺导管腺癌患者的预后价值。
Pancreas. 2022 Feb 1;51(2):148-152. doi: 10.1097/MPA.0000000000001985.
2
Impact of sarcopenia on prediction of progression-free survival and overall survival of patients with pancreatic ductal adenocarcinoma receiving first-line gemcitabine and nab-paclitaxel chemotherapy.肌肉减少症对接受一线吉西他滨和纳米白蛋白紫杉醇化疗的胰腺导管腺癌患者无进展生存期和总生存期预测的影响
Pancreatology. 2022 Mar;22(2):277-285. doi: 10.1016/j.pan.2021.12.013. Epub 2021 Dec 31.
3
An exploratory study of serum creatine kinase as a prognostic marker for patients with resectable pancreatic cancer: looking into the relationship with body composition.
血清肌酸激酶作为可切除胰腺癌患者预后标志物的探索性研究:探究其与身体成分的关系
Nutr J. 2025 Feb 1;24(1):22. doi: 10.1186/s12937-025-01084-x.
4
Prevalence of Sarcopenia Determined by Computed Tomography in Pancreatic Cancer: A Systematic Review and Meta-Analysis of Observational Studies.通过计算机断层扫描确定的胰腺癌患者肌肉减少症的患病率:观察性研究的系统评价和荟萃分析
Cancers (Basel). 2024 Sep 30;16(19):3356. doi: 10.3390/cancers16193356.
5
Role of Body Composition in Patients with Resectable Pancreatic Cancer.可切除胰腺癌患者的体成分作用。
Nutrients. 2024 Jun 11;16(12):1834. doi: 10.3390/nu16121834.
6
Skeletal Muscle Mass Index Reduction Rate as a Prognostic Indicator for Patients Undergoing Pancreatectomy for Pancreatic Cancer.骨骼肌质量指数降低率作为胰腺癌患者接受胰腺切除术后的预后指标
Cancer Diagn Progn. 2024 May 3;4(3):301-308. doi: 10.21873/cdp.10324. eCollection 2024 May-Jun.
7
Association between preoperative sarcopenia and prognosis of pancreatic cancer after curative-intent surgery: a updated systematic review and meta-analysis.术前骨骼肌减少症与根治性手术后胰腺癌预后的关系:一项更新的系统评价和荟萃分析。
World J Surg Oncol. 2024 Jan 30;22(1):38. doi: 10.1186/s12957-024-03310-y.
Prognostic significance of skeletal muscle decrease in unresectable pancreatic cancer: Survival analysis using the Weibull exponential distribution model.
不可切除胰腺癌中骨骼肌减少的预后意义:使用威布尔指数分布模型的生存分析
Pancreatology. 2021 Aug;21(5):892-902. doi: 10.1016/j.pan.2021.03.002. Epub 2021 Mar 6.
4
Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.术前肌少症与胰十二指肠切除术后胰腺癌患者的总体生存不良相关。
Eur Radiol. 2021 Apr;31(4):2472-2481. doi: 10.1007/s00330-020-07294-7. Epub 2020 Sep 24.
5
The impact of sarcopenia and decrease in skeletal muscle mass in patients with advanced pancreatic cancer during FOLFIRINOX therapy.晚期胰腺癌患者在接受FOLFIRINOX治疗期间肌肉减少症及骨骼肌质量下降的影响
Br J Nutr. 2021 May 28;125(10):1140-1147. doi: 10.1017/S0007114520003463. Epub 2020 Sep 4.
6
Pancreatic cancer.胰腺癌。
Lancet. 2020 Jun 27;395(10242):2008-2020. doi: 10.1016/S0140-6736(20)30974-0.
7
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
8
Cancer‑associated adipocytes exhibit distinct phenotypes and facilitate tumor progression in pancreatic cancer.癌相关脂肪细胞表现出独特的表型,并促进胰腺癌的肿瘤进展。
Oncol Rep. 2019 Dec;42(6):2537-2549. doi: 10.3892/or.2019.7365. Epub 2019 Oct 10.
9
Cancer statistics for adults aged 85 years and older, 2019.2019 年 85 岁及以上成年人癌症统计数据。
CA Cancer J Clin. 2019 Nov;69(6):452-467. doi: 10.3322/caac.21577. Epub 2019 Aug 7.
10
Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.肌肉减少症和肌肉减少症性肥胖是可切除胰腺导管腺癌的独立不良预后因素。
PLoS One. 2019 May 6;14(5):e0215915. doi: 10.1371/journal.pone.0215915. eCollection 2019.